Building Robust Molecular & Cellular-Based Assays for mRNA & gRNA Encapsulated Lipid Nanoparticles
Time: 9:30 am
day: Conference Day Two
Details:
- Characterizing priority assays which are pivotal to validate the key mechanisms of action
- Showcasing the shift in approach to potency assay development when handling co-formulated lipid nanoparticles
- Overcoming the challenges faced when utilizing cell-based assays to minimize sample variability
